Live Symposium
The drug discovery landscape is rapidly evolving, driven by advances in artificial intelligence (AI), computational modeling, and experimental techniques. These ongoing developments are enabling researchers to search and develop new therapeutics more efficiently and effectively. In this two-day symposium, experts from industry and academia will discuss the latest trends, emerging technologies, and novel methodologies driving drug development forward.
Topics to be covered
- Computational approaches for target identification and drug repurposing
- CRISPR, organ-on-a-chip, and in vitro models for enhancing preclinical research
- How AI is driving new antibiotic discoveries and drug development strategies
- High throughput screening technologies for accelerating drug discovery pipelines
- Systems pharmacology and mathematical models for optimizing therapy design
Agenda Coming Soon!
Wednesday May 21st - Thursday May 22nd, 2025
11:00 AM - 4:00 PM Eastern Time
This symposium will be available to view live and on demand.
Gabriele Corso, PhD
Research Scientist
Massachusetts Institute of Technology
Melanie Homberg, PhD
Market Development Manager
Lonza
Aurita Menezes, PhD
Associate Director, Market Strategy
Lonza
Kevin Grady
Associate Director, Market Strategy
Lonza
Rada Savic, PhD
Professor
University of California
Ziaurrehman Tanoli, PhD
Principal Investigator
University of Helsinki
.png "Emily Richardson, PhD")
Emily Richardson, PhD
Lead Scientist
CN Bio
Yassen Abbas, PhD
Lead Scientist
CN Bio
Jon Stokes, PhD
Assistant Professor
McMaster University
Milan Mrksich, PhD
Henry Wade Rogers Professor
Northwestern University
Ekta Khurana, PhD
Associate Professor
Cornell University
Zev Wisotsky, PhD
Senior Principal Marketing Manager
Revvity Signals
Samantha Jeschonek, PhD
Product Manager
Revvity Signals
Executive Sponsor
Premium Sponsors
Standard Sponsors
